Getinge Ab Class B · OMXSTO:GETI_B
Getinge Ab Class B — Carnegie Nordic Health Care Seminar 2010
19 slides from Getinge Ab Class B's conference presentation, Mar 24, 2010
Slide 1: Carnegie Nordic Health Care Seminar
GETINGE GROUP Carnegie Nordic Health Care Seminar Johan Malmquist, CEO 24 March, 2010
Slide 2: A rapidly expanding medical technology company
A rapidly expanding medical technology company Medical Systems Extended Care Infection Control GETINGE GROUP March 2010
Slide 3: A rapidly expanding medical technology company
A rapidly expanding medical technology company 2003 2008 1993 1996 Acquisition of Acquisition of Getinge AB is listed Acquisition of the Siemens LSS & Boston Scientific on the Stockholm american Jostra CS/VS divisions Stock Exchange company MDT 1989 1995 2000 2007 2009 Carl Bennet & Rune Getinge acq
Slide 4: Continuous growth 1993 – 2009
Continuous growth 1993 – 2009 CAGR Revenue: 22 % CAGR Profit before tax: 21 % CAGR Organic growth: 6-7% GETINGE GROUP March 2010
Slide 5: Getinge Group 2009
Getinge Group 2009 Revenue: SEK 23 billion Associates: 12 100 Infection Control 22% Critical Care 22% Medical Systems 49% Cardiovascular 45% Extended Surgical Care 29% Workplaces 33% Revenue by Business Area Revenue by division in Medical Systems 5 GETINGE GROUP March 2010
Slide 6: Strategic Direction
GETINGE GROUP STRATEGIC DIRECTION
Slide 7: Well positioned
Well positioned Getinge has gained a competitive position in its markets that will be further strengthened by current trends: • Market testing/privatization • Activity based reimbursement • Focus on core competencies GETINGE GROUP March 2010
Slide 8: Getinge has built a competitive business supported by a robust strategy
Getinge has built a competitive business supported by a robust strategy: Global leadership Solution provider Customer relationships We strive to be a global We strive to combine A direct approach to No 1 or No 2 in the the strength of our our customers is product areas focused. leading product cruci
Slide 9: Strategic direction
Strategic direction Global leadership Integrated solutions Sterilization no 1 Integrated Infection Control Disinfection no 1 solutions Patient Handling no 1 Hygiene Systems no 1 Integrated solutions Wound Care/TS no 2 for health care IPC / DVT no 1 ergonomics Surgical Tables no 1 Surgical Lights no
Slide 10: New Financial Targets and How We Reach Them
NEW FINANCIAL TARGETS AND HOW WE REACH THEM
Slide 11: Getinge Group financial targets
Getinge Group financial targets • Pre-tax earnings: Average growth of 15% per year • Long-term organic revenue growth: 5% (next 3-5 years 2% above market, i.e 7%) • EBITA margin: ~ 20% (MS: 22%, EC: 19%, IC: 16%) • Cash conversion: 60-70% of EBITDA GETINGE GROUP March 2010
Slide 12: We expect to outgrow the markets we serve
We expect to outgrow the markets we serve by 2 % over the next 3-5 years • Revenue synergies from recent major acquisitions • R&D investments in recent years have significantly increased our available markets • We will continue to invest in proprietary sales channels in emerging economies GETINGE GR
Slide 13: We expect EBITA margins to continue to improve in future years
We expect EBITA margins to continue to improve in future years • The acquisitions of Huntleigh, Datascope and the Cardiac and Vascular surgery divisions of Boston Scientific represents SEK 600 – 700 M in annual cost synergies • New and pending product introductions are associated with higher gross m
Slide 14: External Growth
GETINGE GROUP EXTERNAL GROWTH
Slide 15: External Growth
External Growth Reinforcing existing leadership positions • We expect bolt-on acquisitions to add approximately. 2% growth per year. Focus: New technology and geographic expansion Strengthening our capabilities as a solution provider • We expect acquisitions of new and leading product lines that wil
Slide 16: Outlook 2010
GETINGE GROUP OUTLOOK 2010
Slide 17: Outlook 2010
Outlook 2010 • We expect good improvements in organic revenue growth • Improving demand situation in USA and emerging markets • Stable or somewhat declining demand situation in Europe • Continued good growth in pre-tax profit • Restructuring costs will drop significantly in 2010 • Earnings will bene
Slide 18: A different Getinge
A different Getinge Getinge Recent structural changes have improved our earnings quality • Enhanced exposure to therapeutic disciplines • Reduced dependence on capital equipment sales • Systematic investments in the Group’s sales organisation in emerging economies GETINGE GROUP March 2010
Slide 19: Questions & Answers
GETINGE GROUP QUESTIONS & ANSWERS
Getinge Group — Carnegie Nordic Health Care Seminar 2010 on 6ix